FOXP4 and hepatocellular carcinoma: Next, Teufel et al. [13] demonstrated FOXP4 as a tumor suppressor in patients with kidney tumors in 2003 and Wang et al. [30] reported FOXP4 as an oncogene in HCC in 2015.